Endolytix Technology, Inc.

Amendment
CIK: 0001853367·Pharmaceuticals·DELAWARE·Filed: Sep 13, 2023
Total Offering

$4,300,000

Amount Sold

$4,300,000

Investors

14

First Sale

Jul 14, 2023

Offering Details

Type
Debt
Exemptions
Section 4(a)(2), Rule 506(b)
Entity Type
Corporation
Year Incorporated
2020
Non-Accredited Investors
No

Related Persons

NameRole
Ron Zwanziger
Related Person
Rouxi Hu
Related Person
Westly Nolin
Related Person

Company

Endolytix Technology, Inc.

48 Dunham Ridge

BEVERLY, MA, 01915

(978)223-8294

SEC Filing

0001853367-23-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Endolytix Technology, Inc. Form D Filing — $4,300,000 | FilingFlow